Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
08/06/2026 07:04
BRIEF-Moberg Pharma And Karo Healthcare Expand Collaboration June 8 (Reuters) - Moberg Pharma AB (publ) MBPH.ST:
CO AND KARO HEALTHCARE EXPAND COLLABORATION FOR MOB-015/TERCLARA TO CHINA
ESTIMATES ANNUAL WORLDWIDE PEAK SALES POTENTIAL FOR MOB-15 AT $250–500 MILLION
Source text: ID:nWkr3sf9J8
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains